Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Additional adverse reactions added to Flovent's package insert

Feb. 15, 1999

Inflazyme and HMR to collaborate on allergy, asthma and respiratory disease therapies

Feb. 10, 1999

Picroliv now reported to possess promising antiallergic activity

Feb. 9, 1999

Byk Gulden's roflumilast in clinical trials; spotlight on PDE4 inhibitors for asthma

Feb. 9, 1999

Antiallergic/antiasthmatic agents from Kaken acting specifically on eosinophils

Feb. 9, 1999

Discovery's Surfaxin shows positive phase II results in MAS

Feb. 9, 1999

Purinoceptor P2 receptor antagonists in early development at Astra

Feb. 8, 1999

Successful phase II trial of chronic bronchitis treatment reported by Milkhaus

Feb. 5, 1999

Novel mast cell inhibitor tested preclinically for allergy prevention

Feb. 5, 1999

Schering-Plough seeks approval for pediatric use of Nasonex nasal spray

Feb. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...